chromium has been researched along with Cardiovascular Stroke in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (27.59) | 18.7374 |
| 1990's | 1 (3.45) | 18.2507 |
| 2000's | 4 (13.79) | 29.6817 |
| 2010's | 14 (48.28) | 24.3611 |
| 2020's | 2 (6.90) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, R; Barragan, P; Bressollette, E; Chun-Chin, C; Hanratty, CG; Kretov, E; Lesiak, M; McEntegart, MB; Menown, I; Merkulov, E; O'Kane, P; Oldroyd, KG; Onuma, Y; Peace, A; Protopopov, A; Rocchiccioli, P; Silvestri, M; van Geuns, RJ; Wlodarczak, A | 1 |
| Angiolillo, DJ; Baber, U; Bangalore, S; Bhatt, DL; Chandiramani, R; Claessen, BE; Ge, J; Guedeney, P; Hermiller, J; Kozuma, K; Krucoff, M; Liu, Y; Makkar, R; Mehran, R; Neumann, FJ; Rau, V; Saito, S; Seth, A; Sorrentino, S; Valgimigli, M; Vogel, B; Wang, J | 1 |
| Boersma, E; Daemen, J; de Jaegere, PP; Diletti, R; Lemmert, ME; Regar, E; van Bommel, RJ; van Domburg, RT; van Geuns, RJ; van Mieghem, NM; Zijlstra, F | 1 |
| Allocco, DJ; Chen, J; Dawkins, KD; Fu, G; Han, Y; Hong, T; Jiang, T; Li, H; Liu, H; Pang, W; Su, X; Sun, F; Wang, H; Xu, K; Yang, Y; Yuan, Z; Zhang, J; Zhang, M | 1 |
| Allocco, DJ; Christen, T; Crowley, J; Ferrario, M; Jung, W; Legrand, V; MacCarthy, P; Meredith, IT; Moreno, R; Redwood, S; Richardt, G; Schwimmbeck, P; Ungi, I; Werner, N; Zaman, A | 1 |
| Allocco, D; Aquino, M; Batchelor, W; Claessen, BE; Davis, S; Gigliotti, OS; Giugliano, G; Guedeney, P; Haghighat, A; Horwitz, PA; Kandzari, DE; Lopez, M; Mehran, R; Meredith, IT; Othman, I; Singh, S; Sorrentino, S; Tamis, L; Underwood, P; Wang, JC | 1 |
| Brugaletta, S; Cequier, A; de Belder, A; de la Torre Hernandez, JM; Eberli, F; Ferrante, G; Galatius, S; Kaiser, C; Sabaté, M; Serruys, PW; Valgimigli, M | 1 |
| Allocco, DJ; Calabria, P; Capodanno, D; Crowley, JJ; Dawkins, KD; Erglis, A; Gilbert, TJ; Horváth, IG; Menown, IB; Moreno, R; Tamburino, C | 1 |
| Ge, J; Ge, L; Qian, J; Yang, J; Zhang, F; Zhou, J | 1 |
| Byrne, RA; Cassese, S; Colleran, R; de Waha, A; Fusaro, M; Giacoppo, D; Harada, Y; Kastrati, A; Kufner, S; Laugwitz, KL; Ndrepepa, G; Rheude, T; Schunkert, H; Xhepa, E | 1 |
| Asano, T; de Winter, RJ; Dijkstra, J; Jonker, H; Katagiri, Y; Kimura, T; Kozuma, K; Miyazaki, Y; Onuma, Y; Popma, JJ; Serruys, PW; Sotomi, Y; Stone, GW; Tanabe, K; Tenekecioglu, E; Wykrzykowska, JJ | 1 |
| Ahmed, WH; Al-Ama, N; Alissa, EM; Bahjri, SM; Ferns, GA | 1 |
| Afridi, HI; Arain, MB; Baig, JA; Jamali, MK; Kandhro, GA; Kazi, N; Kazi, TG; Khan, S; Kolachi, NF; Shah, AQ; Shah, F; Wadhwa, SK | 1 |
| Chia, S; Choi, LM; Chua, TS; Khin, LW; Koh, AS; Koh, TH; Sim, LL; Tan, JW | 1 |
| Agostoni, P; Belkacemi, A; Doevendans, PA; Nathoe, HM; Politi, L; Sangiorgi, GM; Shao, C; Stella, PR; Van Belle, E; Voskuil, M; Wildbergh, T | 1 |
| Albertucci, M; Biondi-Zoccai, G; Di Giorgio, A; Ficarra, E; Imola, F; Mallus, MT; Monaco, S; Pawlosky, T; Prati, F; Ramazzotti, V | 1 |
| Bae, JW; Chung, WY; Kim, KS; Kim, SY; Lim, SY; Park, HW; Youn, TJ | 1 |
| Arab, L; Bode, P; Gómez-Aracena, J; Guallar, E; Jiménez, FJ; Kark, JD; Kok, FJ; Martín-Moreno, JM; Riemersma, RA; van 't Veer, P | 1 |
| Afridi, HI; Jamali, MK; Kazi, GH; Kazi, TG; Shar, GQ | 1 |
| Abraham, AS; Batt, AP; Eni, M; Shemesh, O; Sonnenblick, M | 1 |
| Polikarpov, BM | 1 |
| Chambless, LE; Fletcher, RH; Hla, KM; Roeback, JR | 1 |
| Arnaud, J; Dumolard, L; Favier, A; Veyrat, B | 1 |
| Versieck, J | 1 |
| Atamanchuk, NS; Polikarpov, BM; Soroka, VR | 1 |
| Draganov, V; Vladimirov, V | 1 |
| Schroeder, HA | 1 |
| Mozhaĭtseva, AG | 1 |
3 review(s) available for chromium and Cardiovascular Stroke
| Article | Year |
|---|---|
Effects of cobalt-chromium everolimus eluting stents or bare metal stent on fatal and non-fatal cardiovascular events: patient level meta-analysis.
Topics: Chromium; Cobalt; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Humans; Myocardial Infarction; Sirolimus; Stents; Thrombosis; Treatment Outcome | 2014 |
[Serum trace elements and myocardial infarction].
Topics: alpha-Macroglobulins; Aspartate Aminotransferases; Chromium; Copper; Creatine Kinase; Humans; L-Lactate Dehydrogenase; Manganese; Myocardial Infarction; Nickel; Selenium; Shock; Time Factors; Trace Elements; Zinc | 1986 |
[Microelements and cardiovascular diseases].
Topics: Angina Pectoris; Animals; Arteriosclerosis; Cadmium; Cardiovascular Diseases; Cerebrovascular Disorders; Chromium; Cobalt; Copper; Humans; Hypercholesterolemia; Hypertension; Manganese; Myocardial Infarction; Nickel; Rabbits; Trace Elements; Zinc | 1974 |
6 trial(s) available for chromium and Cardiovascular Stroke
| Article | Year |
|---|---|
Bioabsorbable polymer drug-eluting stents with 4-month dual antiplatelet therapy versus durable polymer drug-eluting stents with 12-month dual antiplatelet therapy in patients with left main coronary artery disease: the IDEAL-LM randomised trial.
Topics: Absorbable Implants; Chromium; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Humans; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platinum; Polymers; Treatment Outcome | 2022 |
A randomised comparison of biodegradable polymer- and permanent polymer-coated platinum-chromium everolimus-eluting coronary stents in China: the EVOLVE China study.
Topics: Adolescent; Adult; Aged; China; Chromium; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Female; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platinum; Polymers; Sirolimus; Treatment Outcome; Young Adult | 2017 |
Outcomes of patients treated with durable polymer platinum-chromium everolimus-eluting stents: a meta-analysis of randomised trials.
Topics: Aged; Chromium; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Female; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platinum; Polymers; Treatment Outcome | 2017 |
First results of the DEB-AMI (drug eluting balloon in acute ST-segment elevation myocardial infarction) trial: a multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in primary p
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Chromium; Cobalt; Coronary Angiography; Coronary Restenosis; Drug-Eluting Stents; Female; Follow-Up Studies; Heart Conduction System; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Research Design; Risk Assessment; Risk Factors; Single-Blind Method; Stents; Time Factors; Tomography, Optical Coherence; Treatment Outcome | 2012 |
The efficacy and safety of PRO-kinetic metal alloy stent in hospitalized patients with acute ST-elevation myocardial infarction (The PROMETHEUS Study).
Topics: Acute Disease; Adult; Aged; Alloys; Angioplasty, Balloon, Coronary; Carbon Compounds, Inorganic; Chi-Square Distribution; Chromium; Coated Materials, Biocompatible; Cobalt; Coronary Angiography; Electrocardiography; Female; Follow-Up Studies; Hospital Mortality; Hospitalization; Humans; Korea; Male; Metals; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Prospective Studies; Prosthesis Design; Recurrence; Risk Assessment; Severity of Illness Index; Silicon Compounds; Stents; Time Factors; Treatment Outcome | 2012 |
Effects of chromium supplementation on serum high-density lipoprotein cholesterol levels in men taking beta-blockers. A randomized, controlled trial.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Amino Acids; Cholesterol, HDL; Chromium; Confidence Intervals; Double-Blind Method; Follow-Up Studies; Humans; Hypertension; Male; Middle Aged; Myocardial Infarction; Nicotinic Acids; Patient Compliance | 1991 |
20 other study(ies) available for chromium and Cardiovascular Stroke
| Article | Year |
|---|---|
Long-Term Safety and Efficacy of Durable Polymer Cobalt-Chromium Everolimus-Eluting Stents in Patients at High Bleeding Risk: A Patient-Level Stratified Analysis From Four Postapproval Studies.
Topics: Aged; Aged, 80 and over; Cause of Death; Chromium; Cobalt; Comorbidity; Coronary Restenosis; Coronary Stenosis; Coronary Thrombosis; Drug Therapy, Combination; Drug-Eluting Stents; Everolimus; Female; Hemorrhage; Hemorrhagic Disorders; Humans; Kaplan-Meier Estimate; Male; Metabolic Syndrome; Middle Aged; Mortality; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Polymers; Prevalence; Proportional Hazards Models; Prospective Studies; Registries; Smoking; Treatment Outcome | 2020 |
The Promus Premier everolimus-eluting platinum chromium stent with durable polymer evaluated in a real world all-comer population in Rotterdam cardiology hospital (the P-SEARCH registry).
Topics: Aged; Angina, Stable; Chromium; Cohort Studies; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Netherlands; Percutaneous Coronary Intervention; Platinum; Polymers; Prospective Studies; Registries | 2017 |
Clinical outcomes in unselected patients treated with the PROMUS Element platinum-chromium, everolimus-eluting stent: Final five-year results from the PE PROVE Study.
Topics: Cardiovascular Agents; Chromium; Coronary Artery Disease; Coronary Thrombosis; Drug-Eluting Stents; Europe; Everolimus; Female; Humans; Male; Myocardial Infarction; Percutaneous Coronary Intervention; Platinum; Prospective Studies; Prosthesis Design; Registries; Risk Factors; Time Factors; Treatment Outcome | 2019 |
Small-vessel PCI outcomes in men, women, and minorities following platinum chromium everolimus-eluting stents: Insights from the pooled PLATINUM Diversity and PROMUS Element Plus Post-Approval studies.
Topics: Aged; Cardiovascular Agents; Chromium; Coronary Artery Disease; Coronary Thrombosis; Drug-Eluting Stents; Everolimus; Female; Health Status Disparities; Humans; Male; Middle Aged; Minority Health; Myocardial Infarction; Observational Studies as Topic; Percutaneous Coronary Intervention; Platinum; Prosthesis Design; Race Factors; Registries; Retrospective Studies; Risk Factors; Sex Factors; Time Factors; Treatment Outcome; United States | 2019 |
One-year outcomes in unselected patients treated with a thin-strut, platinum-chromium, paclitaxel-eluting stent: primary endpoint results from the TAXUS Element European post-approval surveillance study (TE-PROVE).
Topics: Aged; Cardiovascular Diseases; Chromium; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Europe; Female; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Paclitaxel; Percutaneous Coronary Intervention; Platinum; Product Surveillance, Postmarketing; Prospective Studies; Reoperation; Treatment Failure; Treatment Outcome; Tubulin Modulators | 2015 |
Comparison of long-term clinical outcomes after the second-generation cobalt-chromium sirolimus-eluting stents implantation in diabetic versus non-diabetic patients: a subgroup analysis from the prospective FOCUS registry.
Topics: Aged; Chromium; Cobalt; Coronary Artery Disease; Diabetes Mellitus; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Prospective Studies; Sirolimus; Treatment Outcome | 2016 |
Is quantitative coronary angiography reliable in assessing the late lumen loss of the everolimus-eluting bioresorbable polylactide scaffold in comparison with the cobalt-chromium metallic stent?
Topics: Absorbable Implants; Cardiovascular Agents; Chromium; Cobalt; Coronary Angiography; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Female; Humans; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Sirolimus | 2017 |
Chromium status and glucose tolerance in Saudi men with and without coronary artery disease.
Topics: Adult; Aged; Blood Glucose; Case-Control Studies; Chromium; Coronary Artery Disease; Glucose Tolerance Test; Humans; Lipid Peroxides; Lipids; Male; Middle Aged; Myocardial Infarction; Risk Factors; Saudi Arabia | 2009 |
Chromium and manganese levels in biological samples of Pakistani myocardial infarction patients at different stages as related to controls.
Topics: Case-Control Studies; Chromium; Female; Humans; Male; Manganese; Middle Aged; Myocardial Infarction; Pakistan; Reproducibility of Results; Spectrophotometry, Atomic | 2011 |
Comparing the use of cobalt chromium stents to stainless steel stents in primary percutaneous coronary intervention for acute myocardial infarction: a prospective registry.
Topics: Aged; Angioplasty, Balloon, Coronary; Chromium; Cobalt; Female; Humans; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Recurrence; Registries; Singapore; Stainless Steel; Stents; Survival Analysis; Treatment Outcome | 2011 |
Early vessel healing of the Avantgarde cobalt-chromium coronary stent: the ON-GARDE OCT study.
Topics: Aged; Angioplasty, Balloon, Coronary; Chromium; Cobalt; Coronary Thrombosis; Female; Humans; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Prosthesis Design; Stents; Time Factors; Tomography, Optical Coherence; Treatment Outcome | 2013 |
Low toenail chromium concentration and increased risk of nonfatal myocardial infarction.
Topics: Case-Control Studies; Chromium; Humans; International Cooperation; Male; Middle Aged; Myocardial Infarction; Nails; Neutron Activation Analysis; Risk; Risk Factors; Toes | 2005 |
Essential trace and toxic element distribution in the scalp hair of Pakistani myocardial infarction patients and controls.
Topics: Aged; Aged, 80 and over; Cadmium; Chromium; Copper; Female; Flame Ionization; Hair; Humans; Iron; Lead; Male; Middle Aged; Myocardial Infarction; Nickel; Pakistan; Scalp; Trace Elements; Zinc | 2006 |
Chromium: the forgotten mineral.
Topics: Animals; Chromium; Diabetes Mellitus; Dietary Supplements; Humans; Hypercholesterolemia; Male; Myocardial Infarction; Rats; Weight Loss | 2007 |
Serum chromium in patients with recent and old myocardial infarction.
Topics: Adult; Aged; Blood Glucose; Chromium; Coronary Disease; Female; Humans; Male; Middle Aged; Myocardial Infarction; Time Factors | 1980 |
[Disorder of chromium metabolism in myocardial infarct].
Topics: Adult; Aged; Chromium; Female; Humans; Male; Middle Aged; Myocardial Infarction; Myocardium | 1975 |
[Behavior of the trace element chromium in coronary arteriosclerosis].
Topics: Chromium; Coronary Disease; Follow-Up Studies; Humans; Myocardial Infarction | 1986 |
[Disorders of metabolism of certain trace elements in myocardial infarct].
Topics: Adult; Aged; Aluminum; Chromium; Copper; Female; Humans; Male; Manganese; Middle Aged; Myocardial Infarction; Myocardium; Trace Elements | 1974 |
The role of trace elements in cardiovascular diseases.
Topics: Africa; Animals; Aorta; Arteriosclerosis; Asia; Blood Pressure; Cardiovascular Diseases; Chromium; Coronary Disease; Deficiency Diseases; Diet; Drinking; Endomyocardial Fibrosis; Europe; Geography; Humans; Hypertension; Japan; Manganese; Myocardial Infarction; Rats; Trace Elements; United States; Water; Water Supply | 1974 |
[Blood level dynamics of copper, titanium and chromium in patients with ischemic heart disease].
Topics: Adult; Aged; Angina Pectoris; Chromium; Chronic Disease; Copper; Coronary Disease; Female; Humans; Male; Middle Aged; Myocardial Infarction; Titanium | 1970 |